Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TICH-3 / DASH-2: tranexamic acid and optional desmopressin for very early intracerebral hemorrhage
ISRCTN97695350Phase 3Recruiting
- Sponsor
- University of Nottingham
- Start
- Mar 2022
- Modality
- Small Molecules, Peptides
01
Overview
Phase 3 trial of tranexamic acid and desmopressin, sponsored by University of Nottingham. Started Mar 2022; status: recruiting.
02
Drugs
tranexamic aciddesmopressin
Beyond the preview
Go deeper on ISRCTN97695350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN97695350.